No Data
No Data
William Blair Maintains Century Therapeutics(IPSC.US) With Hold Rating
Piper Sandler Maintains Century Therapeutics(IPSC.US) With Buy Rating, Maintains Target Price $2
Analysts Offer Insights on Healthcare Companies: Becton Dickinson (BDX), Intuitive Surgical (ISRG) and Century Therapeutics (IPSC)
Piper Sandler Remains a Buy on Century Therapeutics (IPSC)
Century Therapeutics (IPSC) Gets a Hold From William Blair
Scion Life Sciences Expands Team With Appointment of Three Venture Partners